Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess
Clinical trial NCT03882034 · COMPLETED
Trial details
- NCT number
- NCT03882034
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-21
- Primary completion
- 2025-09-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.